DaBomb Protein Biotech (6578) reported revenue of NT$40.1 million for Oct 2026, +45.4% year on year and +15.9% from the previous month. Revenue for Jan–Oct 2026 was NT$336 million (+31.2% year on year).
Revenue for Oct 2026 was a record high (previous high: Apr 2024, NT$39.9 million). →
Year-on-year revenue growth: 6 months in a row. →
In Oct 2026, it ranked No. 3 by revenue among 4 Agritech companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$40.1 million | +45.4% | +15.9% |
| Sep 2026 | NT$34.6 million | +29.7% | +1.7% |
| Aug 2026 | NT$34 million | +97.4% | -9.8% |
| Jul 2026 | NT$37.7 million | +50.4% | +7.0% |
| Jun 2026 | NT$35.2 million | +35.8% | -1.8% |
| May 2026 | NT$35.9 million | +27.2% | -1.4% |
| Apr 2026 | NT$36.4 million | -1.0% | +7.1% |
| Mar 2026 | NT$34 million | +24.0% | +52.2% |
| Feb 2026 | NT$22.3 million | +40.0% | -13.4% |
| Jan 2026 | NT$25.8 million | +2.1% | -10.7% |
| Dec 2025 | NT$28.9 million | +74.7% | +18.1% |
| Nov 2025 | NT$24.5 million | -30.2% | -11.3% |
| Oct 2025 | NT$27.6 million | -8.4% | +3.4% |
| Sep 2025 | NT$26.7 million | +101.8% | +54.8% |
| Aug 2025 | NT$17.2 million | -20.9% | -31.3% |
| Jul 2025 | NT$25.1 million | +14.2% | -3.4% |
| Jun 2025 | NT$25.9 million | +37.4% | -8.0% |
| May 2025 | NT$28.2 million | -28.1% | -23.2% |
| Apr 2025 | NT$36.7 million | -7.9% | +34.0% |
| Mar 2025 | NT$27.4 million | -20.4% | +71.8% |
| Feb 2025 | NT$16 million | -40.7% | -36.8% |
| Jan 2025 | NT$25.2 million | -36.7% | +52.7% |
| Dec 2024 | NT$16.5 million | -52.8% | -52.8% |
| Nov 2024 | NT$35.1 million | +2.4% | +16.6% |
| Oct 2024 | NT$30.1 million | -4.1% | +127.6% |
Jan–Oct 2026 cumulative: NT$336 million (+31.2% YoY)
Other Agritech companies
Compare with peers: DaBomb Protein Biotech vs Morn Sun Feed Mill / DaBomb Protein Biotech vs Huikwang / DaBomb Protein Biotech vs GeneReach Biotechnology
| Company | Revenue | YoY |
|---|---|---|
| Morn Sun Feed Mill | NT$228 million | -3.0% |
| Huikwang | NT$114.5 million | +42.1% |
| GeneReach Biotechnology | NT$21.7 million | +12.3% |
Company remark (original Chinese)
1.自2022/10以來,單月營收重返4000萬門檻。2.本年度累計營收已達預算目標,並超越去年全年營收。
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16